RBPMS Is Differentially Expressed in High-Grade Serous Ovarian Cancers

Total Page:16

File Type:pdf, Size:1020Kb

RBPMS Is Differentially Expressed in High-Grade Serous Ovarian Cancers 1 RBPMS is differentially expressed in high-grade serous ovarian cancers. 2 3 Shahan Mamoor1 1 4 [email protected] East Islip, NY 11730 5 6 Ovarian cancer is the most lethal gynecologic cancer1. We sought to identify genes associated 7 with high-grade serous ovarian cancer (HGSC) by comparing global gene expression profiles of 8 normal ovary with that of primary tumors from women diagnosed with HGSC using published microarray data2,3. We found significant differential expression of RBPMS in high-grade serous 9 ovarian tumors. 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Keywords: ovarian cancer, high-grade serous ovarian cancer, HGSC, targeted therapeutics in 26 ovarian cancer, systems biology of ovarian cancer, RBPMS. 27 28 PAGE 1 OF 13 1 The five-year survival rate for women diagnosed with high-grade serous ovarian cancer is 2 between 30-40% and has not changed significantly in decades4,5. The development of novel, 3 4 targeted therapeutics to treat HGSC can be facilitated by an enhanced understanding of the 5 transcriptional behavior of ovarian tumors relative to that of the normal ovary. We mined 6 2,3 7 published microarray data to compare global gene expression profiles between HGSC ovarian 8 tumors and that of normal ovarian tissue. We identified the gene encoding RBPMS as among the 9 most differentially expressed genes in HGSC tumors of the ovary. RBPMS may be a gene of 10 11 interest when prioritizing the study of target genes and pathways for the development of novel 12 therapeutic interventions in high-grade serous ovarian cancers. 13 14 Methods 15 16 We used microarray data from datasets and GSE1247662 and GSE1465563 for this 17 differential gene expression analysis of high-grade serous ovarian carcinomas. The Benjamini 18 19 and Hochberg method of p-value adjustment was used for ranking of differential expression but 20 raw p-values were used for assessment of statistical significance of global differential expression. 21 Log-transformation of data was auto-detected, and the NCBI generated category of platform 22 23 annotation was used. GSE124766 was generated using Agilent-014850 Whole Human Genome 24 Microarray 4x44K G4112F with n=3 of for normal ovarian tissue and n=8 for tumors from 25 26 patients with high-grade serous ovarian cancer. GSE146556 was generated using Affymetrix 27 28 PAGE 2 OF 13 1 Human Gene 1.0 ST Array with n=3 for normal ovarian tissue and n=40 for tumors from patients 2 with high-grade serous ovarian cancer. GEO2R provides mRNA expression levels only for the 3 4 top 250 most differentially expressed genes. 5 6 A statistical test was performed to evaluate whether RBPMS expression was significantly 7 different when comparing normal ovarian tissue from control subjects and primary tumors from 8 women diagnosed with HGSC using a two-tailed, unpaired t-test with Welch’s correction. Only 9 10 p-values less than 0.05 were considered statistically significant. We used PRISM for all statistical 11 analyses (Version 8.4.0)(455). 12 13 Results 14 We mined published microarray data2,3 to identify differentially expressed genes in high- 15 16 grade serous ovarian cancer (HGSC), the type of ovarian cancer responsible for 70-80% of 17 deaths resulting from the most lethal gynecologic malignancy. 18 19 RBPMS is differentially expressed in ovarian tumors from women diagnosed with HGSC. 20 21 We identified the gene encoding RBPMS as among the genes whose expression was most 22 23 different when comparing primary HGSC tumors to normal ovarian tissue2 (Table 1). We found 24 that RBPMS was differentially expressed in primary HGSC tumors (Table 1). When sorting all 25 26 of the transcripts measured by microarray based on change in expression between HGSC and the 27 normal ovary, RBPMS ranked 132 out of 41093 total transcripts (Table 1). Differential 28 PAGE 3 OF 13 1 expression of RBPMS in HGSC tumors was statistically significant (Table 1; p=5.05E-06). 2 We analyzed a second microarray dataset3 generated using normal ovarian tissues and 3 4 tumors from women diagnosed with HGSC to determine whether differential expression of 5 RBPMS could be observed in tumors from a separate group of patients. We again found that 6 7 RBPMS was differentially expressed in primary HGSC tumors (Table 2). When sorting all of the 8 transcripts measured by microarray based on change in expression between HGSC and the 9 normal ovary, in this data set, RBPMS ranked 2212 out of 29088 total transcripts (Table 2). 10 11 Differential expression of RBPMS in HGSC tumors in this second microarray dataset was 12 statistically significant (Table 2; p=1.23E-03). 13 14 RBPMS is expressed at lower levels in HGSC when compared to the normal ovary. 15 16 We obtained exact mRNA expression levels for the differentially expressed RBPMS 17 transcript from both normal ovarian tissue and from high-grade serous ovarian tumors. RBPMS 18 was expressed at lower levels in high-grade serous ovarian cancers when compared to the normal 19 20 ovary; this difference was statistically significant (Figure 1; p=0.0026). We calculated a mean 21 fold change of 0.7338 ± 0.0466 in RBPMS expression when comparing HGSC tumors to normal 22 ovarian tissue (Table 1). 23 24 Thus, we found using published microarray data that RBPMS was among the genes most 25 26 differentially expressed in tumors from women with high-grade serous carcinomas and that 27 RBPMS expression was lower in HGSC tumors when compared to the normal ovary. 28 PAGE 4 OF 13 1 Discussion 2 Transcriptional profiling of HGSC in a Cancer Genome Atlas integrated genomic analysis 3 4 classified HGSC into four subtypes based on gene clustering: immunoreactive, differentiated, 5 proliferative, and mesenchymal6. We sought to continue to describe the transcriptional landscape 6 6 7 of high-grade serous ovarian cancers and identify genes whose differential expression was 8 associated with HGSC by using published microarray data from primary tumors of women 9 diagnosed with HGSC compared to transcriptome data from normal ovarian tissue2,3. In both 10 11 datasets analyzed, RBPMS was among the genes whose expression changed most significantly 12 when comparing the normal ovary to primary HGSC tumors. 13 14 RBPMS, or RNA-binding protein with multiple splicing, is an RNA-binding protein and 15 the human homologue of Xenopus Hermes7. RBPMS is one member of a large family of RRM 16 17 (RNA Recognition Motif) proteins that possess one RRM motif. Highest expression of RBPMS 18 is in the developing heart8. In the vegetal cortex of the Xenopus oocyte, Hermes is degraded 19 20 within hours during oocyte maturation, and depletion of Hermes results in cleavage defects of 21 vegetal blastomeres9. In stage I oocytes, Hermes interacts with nanos and this interaction 22 requires RNA localization signals in the nanos-3’-UTR. hnRNP I also interacts with Hermes and 23 24 may be a co-factor required for the interaction between nanos and Hermes within germinal 25 granules10. In the central nervous system, RBPMS has exclusive expression in retinal ganglion 26 cells, and an established function of RBPMS is in the regulation of axon arbor formation in 27 28 RGC11. Deficiency of Hermes protein in vivo leads to defects in axon arbor complexity in the PAGE 5 OF 13 1 optic tectum in both Xenopus and zebrafish and defects in granule localization11. 2 3 In differentiated vascular smooth muscle cells, RBPMS is a regulator of mRNA splicing. 4 RBPMS expression is down-regulated during switching of SMCs from contractile to motile 5 6 phenotypes; 20% of the alternative splicing (AS) changes during this phenotypic switch could be 7 attributed to RBPMS12. RBPMS regulated alternative splicing of cytoskeletal elements including 8 actin and focal adhesion machinery, as well as splicing of the SMC transcription factor 9 10 Myocardin, suggesting RBPMS is a master regulator of AS in SMCs12. 11 12 Investigators used PAR-CLIP (photo-activatable-ribonucleoside-enhanced cross linking 13 and immunoprecipitation) in HEK293 cells to identify RNA interaction partners of RBPMS and 14 found that RBPMS bound tandem CAC motifs separated by spacers variable in length; in vitro, 15 16 RBPMS could bind (AC)9 and (CAC)6 motifs13. Specific RNA messages bound by RBPMS in 17 PAR-CLIP included NDUFA6, UBE2V1, SRM and ETF113. In the free state, RBPMS forms a 18 symmetrical dimer, and mutations in the dimerization and RNA-binding interface of RRM motif 19 20 result in disruption of RBPMS dimerization and decreased RNA-binding affinity14. 21 22 Multiple studies implicate RBPMS in some aspect of ovarian cancer pathogenesis and in 23 the biology of other human cancers. RBPMS is over-expressed in the A2780 cervical cancer cell 24 line and depletion of RBPMS in A2780 cells using small interfering RNA (siRNA) resulted in an 25 26 increase in invasive potential, while over-expression of RBPMS in cisplatin-resistant 27 A2780CP20 cells resulted in decreases in cell proliferation15. A study identifying differentially 28 expressed genes between recurrent and non-recurrent ovarian cancer found that RBPMS was PAGE 6 OF 13 1 among the most differentially expressed genes (DEGs) between these groups and formed a node 2 when generating a protein-protein interaction network based on interaction between DEGs (16). 3 4 miR-375 was a differentially expressed microRNA in this analysis, and RBPMS was identified 5 as a target gene of miR-37516. Investigators studying miR-21-3p in ovarian cancer found that 6 depletion of miR-21-3p resulted in decreases in proliferation and invasion in vitro; luciferase 7 8 assays identified RBPMS as a target of miR-21-3p17.
Recommended publications
  • Protein Interaction Network of Alternatively Spliced Isoforms from Brain Links Genetic Risk Factors for Autism
    ARTICLE Received 24 Aug 2013 | Accepted 14 Mar 2014 | Published 11 Apr 2014 DOI: 10.1038/ncomms4650 OPEN Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism Roser Corominas1,*, Xinping Yang2,3,*, Guan Ning Lin1,*, Shuli Kang1,*, Yun Shen2,3, Lila Ghamsari2,3,w, Martin Broly2,3, Maria Rodriguez2,3, Stanley Tam2,3, Shelly A. Trigg2,3,w, Changyu Fan2,3, Song Yi2,3, Murat Tasan4, Irma Lemmens5, Xingyan Kuang6, Nan Zhao6, Dheeraj Malhotra7, Jacob J. Michaelson7,w, Vladimir Vacic8, Michael A. Calderwood2,3, Frederick P. Roth2,3,4, Jan Tavernier5, Steve Horvath9, Kourosh Salehi-Ashtiani2,3,w, Dmitry Korkin6, Jonathan Sebat7, David E. Hill2,3, Tong Hao2,3, Marc Vidal2,3 & Lilia M. Iakoucheva1 Increased risk for autism spectrum disorders (ASD) is attributed to hundreds of genetic loci. The convergence of ASD variants have been investigated using various approaches, including protein interactions extracted from the published literature. However, these datasets are frequently incomplete, carry biases and are limited to interactions of a single splicing isoform, which may not be expressed in the disease-relevant tissue. Here we introduce a new interactome mapping approach by experimentally identifying interactions between brain-expressed alternatively spliced variants of ASD risk factors. The Autism Spliceform Interaction Network reveals that almost half of the detected interactions and about 30% of the newly identified interacting partners represent contribution from splicing variants, emphasizing the importance of isoform networks. Isoform interactions greatly contribute to establishing direct physical connections between proteins from the de novo autism CNVs. Our findings demonstrate the critical role of spliceform networks for translating genetic knowledge into a better understanding of human diseases.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Co-Occupancy by Multiple Cardiac Transcription Factors Identifies
    Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart Aibin Hea,b,1, Sek Won Konga,b,c,1, Qing Maa,b, and William T. Pua,b,2 aDepartment of Cardiology and cChildren’s Hospital Informatics Program, Children’s Hospital Boston, Boston, MA 02115; and bHarvard Stem Cell Institute, Harvard University, Cambridge, MA 02138 Edited by Eric N. Olson, University of Texas Southwestern, Dallas, TX, and approved February 23, 2011 (received for review November 12, 2010) Identification of genomic regions that control tissue-specific gene study of a handful of model genes (e.g., refs. 7–10), it has not been expression is currently problematic. ChIP and high-throughput se- evaluated using unbiased, genome-wide approaches. quencing (ChIP-seq) of enhancer-associated proteins such as p300 In this study, we used a modified ChIP-seq approach to define identifies some but not all enhancers active in a tissue. Here we genome wide the binding sites of these cardiac TFs (1). We show that co-occupancy of a chromatin region by multiple tran- provide unbiased support for collaborative TF interactions in scription factors (TFs) identifies a distinct set of enhancers. GATA- driving cardiac gene expression and use this principle to show that chromatin co-occupancy by multiple TFs identifies enhancers binding protein 4 (GATA4), NK2 transcription factor-related, lo- with cardiac activity in vivo. The majority of these multiple TF- cus 5 (NKX2-5), T-box 5 (TBX5), serum response factor (SRF), and “ binding loci (MTL) enhancers were distinct from p300-bound myocyte-enhancer factor 2A (MEF2A), here referred to as cardiac enhancers in location and functional properties.
    [Show full text]
  • Identification of the RNA Recognition Element of the RBPMS Family of RNA-Binding Proteins and Their Transcriptome-Wide Mrna Targets
    Downloaded from rnajournal.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets THALIA A. FARAZI,1,5 CARL S. LEONHARDT,1,5 NEELANJAN MUKHERJEE,2 ALEKSANDRA MIHAILOVIC,1 SONG LI,3 KLAAS E.A. MAX,1 CINDY MEYER,1 MASASHI YAMAJI,1 PAVOL CEKAN,1 NICHOLAS C. JACOBS,2 STEFANIE GERSTBERGER,1 CLAUDIA BOGNANNI,1 ERIK LARSSON,4 UWE OHLER,2 and THOMAS TUSCHL1,6 1Laboratory of RNA Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA 2Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany 3Biology Department, Duke University, Durham, North Carolina 27708, USA 4Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-405 30, Sweden ABSTRACT Recent studies implicated the RNA-binding protein with multiple splicing (RBPMS) family of proteins in oocyte, retinal ganglion cell, heart, and gastrointestinal smooth muscle development. These RNA-binding proteins contain a single RNA recognition motif (RRM), and their targets and molecular function have not yet been identified. We defined transcriptome-wide RNA targets using photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) in HEK293 cells, revealing exonic mature and intronic pre-mRNA binding sites, in agreement with the nuclear and cytoplasmic localization of the proteins. Computational and biochemical approaches defined the RNA recognition element (RRE) as a tandem CAC trinucleotide motif separated by a variable spacer region. Similar to other mRNA-binding proteins, RBPMS family of proteins relocalized to cytoplasmic stress granules under oxidative stress conditions suggestive of a support function for mRNA localization in large and/or multinucleated cells where it is preferentially expressed.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Crystal Structure of Human Acinus RNA Recognition Motif Domain
    Crystal structure of human Acinus RNA recognition motif domain Humberto Fernandes1,2,*, Honorata Czapinska1,*, Katarzyna Grudziaz1, Janusz M. Bujnicki1,3 and Martyna Nowacka1,4 1 International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland 2 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland 3 Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland 4 Current Affiliation: University of Warsaw Biological and Chemical Research Centre, Warsaw, Poland * These authors contributed equally to this work. ABSTRACT Acinus is an abundant nuclear protein involved in apoptosis and splicing. It has been implicated in inducing apoptotic chromatin condensation and DNA fragmentation during programmed cell death. Acinus undergoes activation by proteolytic cleavage that produces a truncated p17 form that comprises only the RNA recognition motif (RRM) domain. We have determined the crystal structure of the human Acinus RRM domain (AcRRM) at 1.65 A˚ resolution. It shows a classical four-stranded antiparallel b-sheet fold with two flanking a-helices and an additional, non-classical a-helix at the C-terminus, which harbors the caspase-3 target sequence that is cleaved during Acinus activation. In the structure, the C-terminal a-helix partially occludes the potential ligand binding surface of the b-sheet and hypothetically shields it from non-sequence specific interactions with RNA. Based on the comparison with other RRM-RNA complex structures, it is likely that the C-terminal a-helix changes its conformation with respect to the RRM core in order to enable RNA binding by Acinus. Submitted 18 April 2018 Accepted 14 June 2018 Published 4 July 2018 Subjects Biochemistry, Molecular Biology Corresponding authors Keywords Acinus, Apoptosis, Crystal structure, RRM domain, Splicing factor Janusz M.
    [Show full text]
  • Identification of High-Confidence RNA Regulatory Elements By
    Li et al. Genome Biology (2017) 18:169 DOI 10.1186/s13059-017-1298-8 METHOD Open Access Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA–protein binding sites Yang Eric Li1†, Mu Xiao2†, Binbin Shi1†, Yu-Cheng T. Yang1, Dong Wang1, Fei Wang2, Marco Marcia3 and Zhi John Lu1* Abstract Crosslinking immunoprecipitation sequencing (CLIP-seq) technologies have enabled researchers to characterize transcriptome-wide binding sites of RNA-binding protein (RBP) with high resolution. We apply a soft-clustering method, RBPgroup, to various CLIP-seq datasets to group together RBPs that specifically bind the same RNA sites. Such combinatorial clustering of RBPs helps interpret CLIP-seq data and suggests functional RNA regulatory elements. Furthermore, we validate two RBP–RBP interactions in cell lines. Our approach links proteins and RNA motifs known to possess similar biochemical and cellular properties and can, when used in conjunction with additional experimental data, identify high-confidence RBP groups and their associated RNA regulatory elements. Keywords: RNA-binding protein, CLIP-seq, Non-negative matrix factorization, RBPgroup Background protein binding sites with high resolution in different RNA-binding proteins (RBPs) are essential to sustain mammalian cells [12–14]. The CLIP-seq data of mul- fundamental cellular functions, such as splicing, polya- tiple RNA binding proteins have been curated and denylation, transport, translation, and degradation of annotated in specific databases, such as CLIPdb, RNA transcripts [1, 2]. One study estimated that more POSTAR, and STARbase [15–17]. Several significant than 1500 different RBPs exist in human [3]. These studies improved the prediction of individual RBPs’ RBPs cooperate or compete with each other in binding binding sites by training on CLIP-seq and RNAcompete their RNA targets [4–6].
    [Show full text]
  • Loss of 13Q Is Associated with Genes Involved in Cell Cycle and Proliferation in Dedifferentiated Hepatocellular Carcinoma
    Modern Pathology (2008) 21, 1479–1489 & 2008 USCAP, Inc All rights reserved 0893-3952/08 $30.00 www.modernpathology.org Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma Britta Skawran1, Doris Steinemann1, Thomas Becker2, Reena Buurman1, Jakobus Flik3, Birgitt Wiese4, Peer Flemming5, Hans Kreipe5, Brigitte Schlegelberger1 and Ludwig Wilkens1,5 1Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany; 2Department of Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany; 3Institute of Virology, Hannover Medical School, Hannover, Germany; 4Institute of Biometry, Hannover Medical School, Hannover, Germany and 5Institute of Pathology, Hannover Medical School, Hannover, Germany Dedifferentiation of hepatocellular carcinoma implies aggressive clinical behavior and is associated with an increasing number of genomic alterations, eg deletion of 13q. Genes directly or indirectly deregulated due to these genomic alterations are mainly unknown. Therefore this study compares array comparative genomic hybridization and whole genome gene expression data of 23 well, moderately, or poorly dedifferentiated hepatocellular carcinoma, using unsupervised hierarchical clustering. Dedifferentiated carcinoma clearly branched off from well and moderately differentiated carcinoma (Po0.001 v2-test). Within the dedifferentiated group, 827 genes were upregulated and 33 genes were downregulated. Significance analysis of microarrays for hepatocellular carcinoma with and without deletion of 13q did not display deregulation of any gene located in the deleted region. However, 531 significantly upregulated genes were identified in these cases. A total of 6 genes (BIC, CPNE1, RBPMS, RFC4, RPSA, TOP2A) were among the 20 most significantly upregulated genes both in dedifferentiated carcinoma and in carcinoma with loss of 13q.
    [Show full text]
  • Identification of the RNA Recognition Element of the RBPMS Family of RNA-Binding Proteins and Their Transcriptome-Wide Mrna Targets
    Downloaded from rnajournal.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets THALIA A. FARAZI,1,5 CARL S. LEONHARDT,1,5 NEELANJAN MUKHERJEE,2 ALEKSANDRA MIHAILOVIC,1 SONG LI,3 KLAAS E.A. MAX,1 CINDY MEYER,1 MASASHI YAMAJI,1 PAVOL CEKAN,1 NICHOLAS C. JACOBS,2 STEFANIE GERSTBERGER,1 CLAUDIA BOGNANNI,1 ERIK LARSSON,4 UWE OHLER,2 and THOMAS TUSCHL1,6 1Laboratory of RNA Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA 2Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany 3Biology Department, Duke University, Durham, North Carolina 27708, USA 4Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-405 30, Sweden ABSTRACT Recent studies implicated the RNA-binding protein with multiple splicing (RBPMS) family of proteins in oocyte, retinal ganglion cell, heart, and gastrointestinal smooth muscle development. These RNA-binding proteins contain a single RNA recognition motif (RRM), and their targets and molecular function have not yet been identified. We defined transcriptome-wide RNA targets using photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) in HEK293 cells, revealing exonic mature and intronic pre-mRNA binding sites, in agreement with the nuclear and cytoplasmic localization of the proteins. Computational and biochemical approaches defined the RNA recognition element (RRE) as a tandem CAC trinucleotide motif separated by a variable spacer region. Similar to other mRNA-binding proteins, RBPMS family of proteins relocalized to cytoplasmic stress granules under oxidative stress conditions suggestive of a support function for mRNA localization in large and/or multinucleated cells where it is preferentially expressed.
    [Show full text]
  • Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 As Wilms' Tumor 1 Target Genes in Podoc
    BASIC RESEARCH www.jasn.org Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb,andMagi2 as Wilms’ Tumor 1 Target Genes in Podocyte Differentiation and Maintenance Lihua Dong,* Stefan Pietsch,* Zenglai Tan,* Birgit Perner,* Ralph Sierig,* Dagmar Kruspe,* † ‡ † Marco Groth, Ralph Witzgall, Hermann-Josef Gröne,§ Matthias Platzer, and | Christoph Englert* Departments of *Molecular Genetics and †Genome Analysis, Leibniz Institute for Age Research, Fritz Lipmann Institute, Jena, Germany; ‡Institute for Molecular and Cellular Anatomy, University of Regensburg, Regensburg, Germany; §Department of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany; and |Faculty of Biology and Pharmacy, Friedrich Schiller University of Jena, Jena, Germany ABSTRACT The Wilms’ tumor suppressor gene 1 (WT1) encodes a zinc finger transcription factor. Mutation of WT1 in humans leads to Wilms’ tumor, a pediatric kidney tumor, or other kidney diseases, such as Denys–Drash and Frasier syndromes. We showed previously that inactivation of WT1 in podocytes of adult mice results in pro- teinuria, foot process effacement, and glomerulosclerosis. However, the WT1-dependent transcriptional net- work regulating podocyte development and maintenance in vivo remains unknown. Here, we performed chromatin immunoprecipitation followed by high-throughput sequencing with glomeruli from wild-type mice. Additionally,weperformedacDNAmicroarrayscreenonaninduciblepodocyte–specific WT1 knockout mouse model. By integration of cistromic
    [Show full text]
  • Identification of RBPMS As a Mammalian Smooth Muscle Master
    RESEARCH ARTICLE Identification of RBPMS as a mammalian smooth muscle master splicing regulator via proximity of its gene with super- enhancers Erick E Nakagaki-Silva1, Clare Gooding1, Miriam Llorian1,2, Aishwarya G Jacob1,3, Frederick Richards1, Adrian Buckroyd1, Sanjay Sinha1,3, Christopher WJ Smith1* 1Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; 2Francis Crick Institute, London, United Kingdom; 3Anne McLaren Laboratory, Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom Abstract Alternative splicing (AS) programs are primarily controlled by regulatory RNA-binding proteins (RBPs). It has been proposed that a small number of master splicing regulators might control cell-specific splicing networks and that these RBPs could be identified by proximity of their genes to transcriptional super-enhancers. Using this approach we identified RBPMS as a critical splicing regulator in differentiated vascular smooth muscle cells (SMCs). RBPMS is highly down- regulated during phenotypic switching of SMCs from a contractile to a motile and proliferative phenotype and is responsible for 20% of the AS changes during this transition. RBPMS directly regulates AS of numerous components of the actin cytoskeleton and focal adhesion machineries whose activity is critical for SMC function in both phenotypes. RBPMS also regulates splicing of other splicing, post-transcriptional and transcription regulators including the key SMC transcription factor Myocardin, thereby matching many of the criteria of a master regulator of AS in SMCs. DOI: https://doi.org/10.7554/eLife.46327.001 *For correspondence: [email protected] Competing interests: The Introduction authors declare that no Alternative splicing (AS) is an important component of regulated gene expression programmes dur- competing interests exist.
    [Show full text]